Search research articles
Contact Us
Filters
Showing results (161-170 of 174) with videos related to
Page
of 18
Sort By:
Cancer Communications (London, England)
|
May 18, 2026
Transcriptional and Epigenetic Plasticity Drive an Alternative Non-clonal Mechanism of Resistance to <i>Kras</i> <sup>G12D</sup> Inhibition in Pancreatic Cancer
Alessia Caggiano, Antonio Agostini, Diego Iacuone, et al.
Life Science Alliance
|
August 6, 2020
Sam68 splicing regulation contributes to motor unit establishment in the postnatal skeletal muscle
Elisa De Paola, Laura Forcina, Laura Pelosi, et al.
Nucleic Acids Research
|
February 7, 2024
Differential expression of paralog RNA binding proteins establishes a dynamic splicing program required for normal cerebral cortex development
Eleonora Cesari, Donatella Farini, Vanessa Medici, et al.
Journal of Medicinal Chemistry
|
August 11, 2025
Ferroptosis Induction by a New Pyrrole Derivative in Triple Negative Breast Cancer and Colorectal Cancer
Domiziana Masci, Lele Ling, Lian Yang, et al.
Cell Reports. Medicine
|
February 7, 2024
An alternative splicing signature defines the basal-like phenotype and predicts worse clinical outcome in pancreatic cancer
Veronica Ruta, Chiara Naro, Marco Pieraccioli, et al.
Journal of Medicinal Chemistry
|
March 25, 2026
Correction to "Ferroptosis Induction by a New Pyrrole Derivative in Triple Negative Breast Cancer and Colorectal Cancer"
Domiziana Masci, Lele Ling, Lian Yang, et al.
Human Mutation
|
November 8, 2021
Clinical variability at the mild end of BRAT1-related spectrum: Evidence from two families with genotype-phenotype discordance
Sara Nuovo, Valentina Baglioni, Roberta De Mori, et al.
Journal of Medicinal Chemistry
|
November 7, 2024
Development of <i>N</i>-(4-(1<i>H</i>-Imidazol-1-yl)phenyl)-4-chlorobenzenesulfonamide, a Novel Potent Inhibitor of β-Catenin with Enhanced Antitumor Activity and Metabolic Stability
Michela Puxeddu, Lele Ling, Silvia Ripa, et al.
Cell Death & Disease
|
March 25, 2026
The ATC12 small molecule inhibits the Aurora-A/TPX2 interaction and impairs the proliferation of breast cancer cells
Dalila Boi, Giulia Fianco, Federica Polverino, et al.
Cell Reports
|
December 24, 2016
A SLM2 Feedback Pathway Controls Cortical Network Activity and Mouse Behavior
Ingrid Ehrmann, Matthew R Gazzara, Vittoria Pagliarini, et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 174) with videos related to
Sort By:
Page
of 18
Cancer Communications (London, England)
|
May 18, 2026
Transcriptional and Epigenetic Plasticity Drive an Alternative Non-clonal Mechanism of Resistance to <i>Kras</i> <sup>G12D</sup> Inhibition in Pancreatic Cancer
Alessia Caggiano, Antonio Agostini, Diego Iacuone, et al.
Life Science Alliance
|
August 6, 2020
Sam68 splicing regulation contributes to motor unit establishment in the postnatal skeletal muscle
Elisa De Paola, Laura Forcina, Laura Pelosi, et al.
Nucleic Acids Research
|
February 7, 2024
Differential expression of paralog RNA binding proteins establishes a dynamic splicing program required for normal cerebral cortex development
Eleonora Cesari, Donatella Farini, Vanessa Medici, et al.
Journal of Medicinal Chemistry
|
August 11, 2025
Ferroptosis Induction by a New Pyrrole Derivative in Triple Negative Breast Cancer and Colorectal Cancer
Domiziana Masci, Lele Ling, Lian Yang, et al.
Cell Reports. Medicine
|
February 7, 2024
An alternative splicing signature defines the basal-like phenotype and predicts worse clinical outcome in pancreatic cancer
Veronica Ruta, Chiara Naro, Marco Pieraccioli, et al.
Journal of Medicinal Chemistry
|
March 25, 2026
Correction to "Ferroptosis Induction by a New Pyrrole Derivative in Triple Negative Breast Cancer and Colorectal Cancer"
Domiziana Masci, Lele Ling, Lian Yang, et al.
Human Mutation
|
November 8, 2021
Clinical variability at the mild end of BRAT1-related spectrum: Evidence from two families with genotype-phenotype discordance
Sara Nuovo, Valentina Baglioni, Roberta De Mori, et al.
Journal of Medicinal Chemistry
|
November 7, 2024
Development of <i>N</i>-(4-(1<i>H</i>-Imidazol-1-yl)phenyl)-4-chlorobenzenesulfonamide, a Novel Potent Inhibitor of β-Catenin with Enhanced Antitumor Activity and Metabolic Stability
Michela Puxeddu, Lele Ling, Silvia Ripa, et al.
Cell Death & Disease
|
March 25, 2026
The ATC12 small molecule inhibits the Aurora-A/TPX2 interaction and impairs the proliferation of breast cancer cells
Dalila Boi, Giulia Fianco, Federica Polverino, et al.
Cell Reports
|
December 24, 2016
A SLM2 Feedback Pathway Controls Cortical Network Activity and Mouse Behavior
Ingrid Ehrmann, Matthew R Gazzara, Vittoria Pagliarini, et al.
Page
of 18